Montelukast Prescribing at THE GOODINGE GROUP PRACTICE
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
544
Total Quantity
16.7K
NHS Cost
£871
vs National Avg
-20.6%
THE GOODINGE GROUP PRACTICE prescribed 544 items of Montelukast over the last 12 months at a cost of £871 to the NHS. This is 20.6% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
45
Jul 2026
40
Jul 2026
48
Jul 2026
52
Jul 2026
30
Jul 2026
50
Jul 2026
36
Jul 2026
54
Jul 2026
35
Jul 2026
55
Jul 2026
50
Jul 2026
49
Prescribing Details
| Total Items | 544 |
|---|---|
| Total Quantity | 16,695 |
| Total NHS Cost | £871 |
| Presentations | 4 different forms |
| vs National Average | -20.6% |
Montelukast Prescribing Comparison
| This practice | 544 items |
|---|---|
| National average per practice | 685 items |
| Difference | -20.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.